Eisuke Murakami
Impact in
- Hepatology top 0.5%
- Hepatitis C virus research
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease and Transplantation
- Infectious Diseases top 2%
- HIV/AIDS drug development and treatment
Papers in
- Hepatology 79
- Hepatitis C virus research 45
- Hepatocellular Carcinoma Treatment and Prognosis 28
- Liver Disease and Transplantation 12
- Epidemiology 57
- Liver Disease Diagnosis and Treatment 43
- Hepatitis B Virus Studies 25
- Co-authors
- Kazuaki Chayama (54 shared papers)Michio Imamura (55 shared papers)Michael J. Sofia (9 shared papers)Phillip A. Furman (12 shared papers)Hiroshi Aikata (53 shared papers)Masataka Tsuge (62 shared papers)Michaël Otto (9 shared papers)Angela M. Lam (8 shared papers)
- Journals
- Hepatology Research (10 papers)Journal of Gastroenterology (9 papers)Antimicrobial Agents and Chemotherapy (7 papers)Oncology (4 papers)Journal of Viral Hepatitis (4 papers)
- Partner nations
- JapanUnited StatesSwitzerland
In The Last Decade
Eisuke Murakami
92 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 84
- Hepatology 1.3k
- Infectious Diseases 658
- Epidemiology 1.1k
- Virology 103
- Cancer Research 129
Countries citing papers authored by Eisuke Murakami
This map shows the geographic impact of Eisuke Murakami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eisuke Murakami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eisuke Murakami more than expected).
Fields of papers citing papers by Eisuke Murakami
This network shows the impact of papers produced by Eisuke Murakami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eisuke Murakami. The network helps show where Eisuke Murakami may publish in the future.
Co-authors
The 25 scholars most cited alongside Eisuke Murakami, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 102 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 254 | |
| 2 | 2010 | 234 | |
| 3 | 2010 | 105 | |
| 4 | 2007 | 96 | |
| 5 | 2012 | 91 | |
| 6 | 2006 | 80 | |
| 7 | 2013 | 71 | |
| 8 | 2013 | 66 | |
| 9 | 2015 | 59 | |
| 10 | 2015 | 57 | |
| 11 | 2012 | 55 | |
| 12 | 2014 | 38 | |
| 13 | 2003 | 36 | |
| 14 | 2014 | 36 | |
| 15 | 2020 | 34 | |
| 16 | 2018 | 33 | |
| 17 | 2018 | 33 | |
| 18 | 2019 | 32 | |
| 19 | 2021 | 32 | |
| 20 | 2013 | 31 |
About Eisuke Murakami
Eisuke Murakami is a scholar working on Hepatology, Epidemiology, Infectious Diseases, Molecular Biology and Oncology, having authored 102 papers that have together received 2.1k indexed citations. Recurring topics across this work include Hepatitis C virus research (45 papers), Liver Disease Diagnosis and Treatment (43 papers), Hepatocellular Carcinoma Treatment and Prognosis (28 papers), Hepatitis B Virus Studies (25 papers), HIV/AIDS drug development and treatment (19 papers), Liver Disease and Transplantation (12 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Biochemical and Molecular Research (7 papers). The work is most often cited by research in Hepatology (1.3k citations), Infectious Diseases (658 citations), Epidemiology (1.1k citations), Virology (103 citations) and Cancer Research (129 citations). Eisuke Murakami has collaborated with scholars based in Japan, United States and Switzerland. Frequent co-authors include Kazuaki Chayama, Michio Imamura, Michael J. Sofia, Phillip A. Furman, Hiroshi Aikata, Masataka Tsuge, Michaël Otto, Angela M. Lam, Tomokazu Kawaoka and Haiying Bao. Their work appears in journals such as Hepatology Research, Journal of Gastroenterology, Antimicrobial Agents and Chemotherapy, Oncology and Journal of Viral Hepatitis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.